Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking
- 19 August 1993
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 100 (8), 721-726
- https://doi.org/10.1111/j.1471-0528.1993.tb14262.x
Abstract
Objective To measure quantitatively and objectively the maternal and fetal tobacco exposure during pregnancy and its neonatal effects. Design Tobacco exposure was assessed from maternal serum samples, obtained during the first half of pregnancy and from umbilical serum samples obtained at delivery, by measuring the concentration of nicotine metabolite, cotinine. Data on the respective pregnancies and neonates were collected from the Finnish Medical Birth Registry. Setting Finland. Subjects One thousand two hundred and thirty-seven pregnancies and newborns, representing all pregnancies resulting in a liveborn infant during one week in one country. Main outcome measures Gestational age, birthweight and crown-heel length of newborns. Results Cotinine (>6 μg/l) was detected in either maternal or umbilical serum in 300 pregnancies, and these mothers and newborns were classified as exposed. Important differences occurred between measured exposure and reported smoking behaviour. Of the exposed mothers, 38% were nonsmokers and 3.4% of the nonexposed mothers were smokers. Tobacco exposure was associated with shorter gestational age, reduced birthweight and shorter crown-heel length of the newborns. After correction for parity, gender, and gestational age, the exposed newborns were on average 188 g (95% confidence interval (CI) 123–253 g) lighter and 10 mm (95% CI7–13 mm) shorter than the nonexposed newborns. One μg/ml of cotinine in maternal serum resulted in a mean decrease of 1.29 g (95% CI 0.55–2.02 g) in birthweight and in a mean decrease of 0.059 mm (95% CI 0.035–0.083 mm) in birth length. Maternal cotinine concentrations better explained the neonatal findings than the reported smoking habits. Conclusions There is a quantitative dose and effect relation between tobacco exposure and a decrease in the gestational age at birth and size of the neonate. The smoking habit reported by mothers themselves is not an accurate measure of fetal tobacco exposure.Keywords
This publication has 14 references indexed in Scilit:
- Tobacco Smoke Exposure and Pregnancy Outcome among Working WomenAmerican Journal of Epidemiology, 1991
- Effect of Passive Smoking during Pregnancy on Selected Perinatal ParametersInternational Journal of Epidemiology, 1990
- Effects on birth weight of smoking, alcohol, caffeine, socioeconomic factors, and psychosocial stress.BMJ, 1989
- Cigarette smoking as risk factor for late fetal and early neonatal death.BMJ, 1988
- Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.American Journal of Public Health, 1988
- Cigarette consumption and serum cotinine in relation to birthweightBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Confidence intervals rather than P values: estimation rather than hypothesis testing.BMJ, 1986
- Cotinine disposition and effectsClinical Pharmacology & Therapeutics, 1983
- Maternal smoking, pregnancy complications, and perinatal mortalityAmerican Journal of Obstetrics and Gynecology, 1977
- A COMMUNITY STUDY OF SMOKING IN PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1972